Home › Graves Disease › Virginia
Graves Disease clinical trials in Virginia
4 studies for Graves Disease are looking for participants at sites in Virginia.
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-073, Midlothian
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 12, 2026 · NCT07661056A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Patient First Clinical Trials (PFCTrials), Richmond
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07722546A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1016, Norfolk
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 30, 2026 · NCT07018323Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
- Virginia Eye Consultants, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07753603From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.